Overview
Pilot Study of APD209 in Cancer Cachexia
Status:
Completed
Completed
Trial end date:
2012-01-01
2012-01-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
Primary Objective: To assess the efficacy of APD209 in adult patients with active cachexia associated with advanced malignancy and not caused by simple starvation. Secondary Objective: To assess the safety of APD209 in patients with advanced malignancy and active cachexia.Phase:
Phase 2Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Acacia Pharma Ltd
Criteria
Inclusion Criteria:- Involuntary loss of weight of >= 2% in 2 months or >= 5% in 6 months, and ongoing in
recent weeks, without (or with successfully treated) secondary causes of impaired oral
nutritional intake (simple starvation).